Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

34.35
Delayed Data
As of 4:02pm ET
 -0.22 / -0.64%
Today’s Change
25.55
Today|||52-Week Range
35.60
+25.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues5.4B5.3B5.1B5.2B
 
 
 
 
 
Cost of Goods Sold436.2M212.0M480.4M189.4M
 
 
 
 
 
Depreciation And Amortization561.5M563.1M537.8M629.4M
 
 
 
 
 
 
Operating ExpensesGross Income4.4B4.5B4.1B4.4B
 
 
 
 
 
General Expenses4.1B3.4B2.4B3.5B
 
 
 
 
 
Other Operating Expenses0.0019.4M20.1M--
 
 
 
Research And Development1.3B1.3B1.4B1.3B
 
 
 
 
 
Total Operating Expenses5.1B4.2B3.5B4.3B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income230.5M1.1B1.6B877.1M
 
 
 
 
 
Extraordinary Credit0.0022.1M0.000.00
 
 
Extraordinary Charge-454.4M-252.5M-359.2M-298.4M
 
 
 
 
 
Interest Expense On Debt151.1M327.1M330.0M325.2M
 
 
 
 
 
Equity In Earnings-7.7M-9.2M-10.0M-12.4M
 
 
 
 
 
Other Expenses353.9M98.6M1.0B298.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.0M632.2M2.0B569.1M
 
 
 
 
 
Income Taxes-956.6K-294.0M-333.6M-67.0M
 
 
 
 
 
Minority Interest-26.8M-17.5M-22.8M-23.9M
 
 
 
 
 
Net Income-2.9M934.4M1.7B513.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.00$0.37$0.67$0.20
 
 
 
 
EPS Diluted-$0.00$0.37$0.66$0.20